• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Aetna in discussion with irate blogger

Article

Narrow networks keep premiums low, but how narrow is too narrow?

When a physician posted a blog publicly announcing her decision to stop serving Aetna members, she wasn’t delicate about the matter. In fact, Kristin S. Held, MD, said she was saddened to think the company made a choice “to collude with big government rather than collaborate with patients and physicians.”

Dr. Held called out the Affordable Care Act, Aetna’s network and its new allowables as reasons for not wanting to continue to contract with the payer.

In an email to MHE, Aetna responded by saying the organization is in discussions with the provider. It also issued a statement about the exchange network:

“Aetna’s exchange network is built with the same goals as our networks for all other commercial medical plans-to deliver access to doctors, hospitals and other providers who provide high quality healthcare services at competitive prices.  Members who purchase health insurance through the public exchanges, and the providers who serve those members, receive the same service and support that we provide for health plans purchased off-exchange.

“We notified providers of their participation in our exchange network as well as any changes in Aetna rates, as required under contract and in accordance with state regulations. If for any reason a provider objects to offering services to members who bought their plan through an exchange, we will work with that provider to address their concerns.”

The back and forth between payer and provider over network status is an emerging trend that has caught the eye of state and federal regulators. Mississippi and Pennsylvania are considering bills that would more tightly regulate the number of doctors and hospitals in a network, while the federal government has released a new proposal that would have insurers submit their network lists for review before being approved to participate on the federally operated exchange.

At the same time, payers know that slimming down their networks to include only more effective, efficient providers is the best way to keep premiums in check.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
© 2024 MJH Life Sciences

All rights reserved.